Hidden dexamethasone in pain relief product Qu Feng Huo Lou Dan has prompted the United States Food and Drug Administration to warn consumers not to purchase or use it. On August 25, 2026, FDA laboratory testing confirmed that the product contained dexamethasone even though the prescription steroid was not declared on its label [1].
Qu Feng Huo Lou Dan was promoted for pain relief through different websites, including the New Green USA website, and may also have been sold through some retail stores. The FDA has specifically advised people who are currently taking the product to contact a healthcare professional immediately so that withdrawal risk can be assessed and the product can be discontinued safely [1].
This is not a minor labelling concern. A person may unknowingly consume a powerful corticosteroid for weeks or months without knowing the dose, interaction risk, infection risk, effect on blood glucose, or danger of sudden withdrawal.
Dexamethasone can make a pain product appear remarkably effective because it rapidly suppresses inflammation. However, the relief may be temporary while natural cortisol production is gradually reduced. If the product is then stopped suddenly, the patient may develop steroid withdrawal symptoms, adrenal insufficiency, or a potentially fatal adrenal crisis.
What Did the FDA Find in Qu Feng Huo Lou Dan?
The FDA found dexamethasone that was not listed among the ingredients of Qu Feng Huo Lou Dan [1]. Dexamethasone is a potent corticosteroid used under medical supervision for selected inflammatory, allergic, neurological, immune, and cancer related conditions.
The medication itself has legitimate medical uses. The danger arises when it is hidden inside a product and consumed without a prescription, dose information, monitoring, or withdrawal plan.
The FDA notice does not state how much dexamethasone was found. It also does not identify a specific lot number or provide information that would allow patients to estimate their daily steroid exposure [1].
The agency published the information as a medication health fraud notification. The notice advises consumers not to purchase or use the product, but it does not identify a conventional lot specific manufacturer recall.
Why Can Hidden Dexamethasone Produce Fast Pain Relief?
Dexamethasone strongly suppresses inflammation and alters immune activity. A person with joint pain, swelling, back pain, muscle pain, arthritis, or another inflammatory condition may therefore feel noticeably better soon after taking it.
The improvement may be so striking that the consumer assumes the product has corrected the underlying disease. In reality, the steroid may only be covering pain and inflammation while the original condition remains active.
Pain can arise from osteoarthritis, rheumatoid arthritis, gout, infection, nerve compression, autoimmune disease, fracture, metabolic illness, or other causes. A hidden steroid may reduce the visible warning signs without correcting the disease responsible for them.
When symptoms return after a dose is missed, the patient may believe that the natural product must be continued. This can create a cycle in which temporary suppression is mistaken for lasting recovery.
The FDA warns that dexamethasone can weaken immune defence, raise blood glucose, damage muscles, and cause mental health problems [1]. Official prescribing information also describes risks involving blood pressure, fluid retention, bone loss, eye complications, infection, mood disturbance, muscle weakness, and adrenal suppression [4].
A patient may therefore feel less pain while other health problems are developing silently.
Why May Sudden Dexamethasone Withdrawal Be Dangerous?
Your adrenal glands produce cortisol, a hormone required for blood pressure regulation, glucose balance, metabolism, immune regulation, and the body’s response to physical stress.
When dexamethasone is taken repeatedly, the brain recognises that a strong external corticosteroid is already present. Signals from the hypothalamus and pituitary gland may decrease, causing the adrenal glands to produce less natural cortisol.
This is known as suppression of the hypothalamic pituitary adrenal axis.
If dexamethasone is removed before the adrenal glands have recovered, the body may temporarily be unable to produce enough cortisol. This can cause glucocorticoid withdrawal symptoms, adrenal insufficiency, or adrenal crisis [2,3].
Current guidance from the European Society of Endocrinology and the Endocrine Society identifies oral glucocorticoid exposure as a recognised concern when both duration and dose exceed expected risk thresholds. The general thresholds are approximately three to four weeks or longer and more than about 0.25 to 0.5 mg dexamethasone per day [2].
These thresholds are clinical guides and not guarantees. Risk varies according to the actual dose, duration, frequency, other steroid exposure, current illness, age, metabolic health, and individual susceptibility.
The problem with Qu Feng Huo Lou Dan is that the dexamethasone dose has not been disclosed. A consumer cannot compare personal exposure with recognised risk thresholds and cannot safely create a withdrawal schedule from the label.
Dexamethasone Withdrawal Symptoms Patients Should Recognise
Steroid withdrawal symptoms may resemble influenza, extreme tiredness, recurrence of arthritis, or worsening of the original pain condition. This overlap can delay diagnosis.
Common symptoms include unusual fatigue, muscle weakness, reduced appetite, nausea, abdominal discomfort, vomiting, diarrhoea, dizziness, body pain, joint pain, headache, and low blood pressure [2,3,4].
Some people may experience withdrawal symptoms even when laboratory testing does not show severe adrenal insufficiency. Others may have reduced cortisol production without obvious symptoms until they develop fever, infection, dehydration, injury, or require surgery.
What Is an Adrenal Crisis?
An adrenal crisis occurs when the body has dangerously insufficient cortisol during illness or another form of physical stress.
Possible signs include severe weakness, repeated vomiting, diarrhoea, abdominal pain, dehydration, confusion, fainting, very low blood pressure, collapse, low blood glucose, and shock [2,3].
This is a medical emergency. A person with suspected adrenal crisis requires immediate hospital treatment, which may include intravenous fluids and medically administered corticosteroids.
Ayurvedic medicine, food, supplements, massage, detoxification, or home remedies cannot replace emergency cortisol treatment during an adrenal crisis.
What Should a Current User of Qu Feng Huo Lou Dan Do?
A person who has not started the product should not purchase or use it.
Someone who is currently taking it should contact a physician or qualified healthcare professional promptly. The FDA specifically recommends professional assessment so the risks of corticosteroid withdrawal can be evaluated and the product can be discontinued safely [1].
The patient should provide the product name, purchase source, date it was started, amount taken, frequency of use, date of the most recent dose, reason for taking it, and any symptoms that appeared after starting or missing a dose.
All other possible steroid exposure must also be disclosed. This includes prescription tablets, injections, inhalers, nasal sprays, eye drops, skin creams, and injections given into joints.
The bottle, remaining tablets, packaging, invoice, and photographs of the label should be retained. These may help the treating clinician and medicine regulator identify the product.
A patient should not create a personal dexamethasone taper from an online schedule. The amount contained in the product is unknown, and a taper designed for a known prescription dose may not match the actual exposure.
Does Every User Require Steroid Tapering?
No. Not every person who has taken the product will require tapering or temporary corticosteroid replacement.
Short exposure is generally associated with a lower risk of prolonged adrenal suppression. Current guidelines suggest that many patients taking prescribed glucocorticoids for less than three to four weeks can stop without tapering because concern about suppression is usually low [2].
However, this guidance assumes that the clinician knows the drug, dose, duration, and frequency. Those details are not available for hidden dexamethasone in Qu Feng Huo Lou Dan.
A physician may decide that immediate discontinuation is appropriate for one patient, while another patient may require supervised dose reduction, temporary replacement with a shorter acting corticosteroid, laboratory testing, or closer monitoring.
The decision should be based on the individual exposure history, symptoms, physical examination, concurrent medicines, and clinical investigations.
How May a Doctor Check for Adrenal Suppression?
The assessment may include blood pressure, hydration, blood glucose, sodium, potassium, and other investigations selected according to the patient’s symptoms and medical history.
When confirmation of adrenal recovery is required, the current endocrine guideline recommends morning serum cortisol as the first investigation [2].
A higher result is more consistent with recovery, while a lower result may indicate that the patient needs continued medical supervision. Some patients may require repeat testing after several weeks or months.
A single test should not be interpreted without considering when the sample was taken, recent steroid exposure, current illness, other medicines, and the patient’s clinical condition.
Who May Require More Careful Monitoring?
Concern may be greater when the product has been taken regularly for several weeks or months, when the dose has increased over time, or when the person becomes weak or unwell after missing it.
People using additional corticosteroids may have greater total exposure than they realise. This includes patients using steroid inhalers, skin preparations, nasal sprays, injections, or prescription tablets at the same time.
Particular attention may also be required for people with diabetes, high blood pressure, osteoporosis, glaucoma, recurrent infections, tuberculosis risk, stomach ulcer disease, mental health disorders, liver disease, or a planned operation.
A patient may have significant adrenal suppression even when pain relief has been excellent and no obvious adverse effect has appeared.
Published Cases Show Why Hidden Steroids Are Serious
A published case series described three patients who developed disruption of the hypothalamic pituitary adrenal axis while using an unregulated joint pain supplement associated with undeclared dexamethasone [5].
Reported problems included weight gain, muscle weakness, abnormal sodium levels, changes in body fat distribution, skin changes, and evidence of suppressed adrenal function.
Another published case described iatrogenic Cushing syndrome after prolonged use of an over the counter arthritis supplement containing dexamethasone that the patient did not know was present [6].
These case reports do not show how frequently complications will occur in every consumer. They demonstrate that undeclared steroids can cause real endocrine disease and that a detailed history of supplements and pain products is clinically important.
Why This FDA Warning Matters in the United Kingdom, Canada, Australia and Singapore
The FDA notification was issued in the United States, but the product was promoted through websites and may cross international borders.
Consumers in the United Kingdom, Canada, Australia, Singapore, and other countries may encounter the same product through online marketplaces, social media sellers, importers, local retailers, or informal distributors.
Anyone who has purchased the product outside the United States should retain the packaging, avoid giving it to another person, inform a healthcare professional, and report it to the relevant national medicine regulator.
The FDA also states that it cannot test and identify every product marketed with hidden pharmaceutical ingredients [1]. A product should therefore not be assumed safe merely because its name does not appear in a regulator’s warning database.
Hidden Dexamethasone Is Not Authentic Ayurveda
A synthetic corticosteroid secretly added to a product promoted as natural should not be confused with authentic Ayurvedic medicine.
Classical Ayurvedic practice requires a known composition, proper preparation, individual assessment, appropriate dose, professional accountability, and continued follow up.
A product with an incomplete label, secret ingredients, unknown manufacturing controls, or an unusually powerful steroid like effect does not represent responsible Ayurveda.
The problem identified by the FDA is adulteration and deception. It is not evidence against the classical Ayurvedic system when Ayurveda is practised transparently and medicines are selected according to the diagnosed condition.
How the Panaceayur Ayurvedic Model Addresses the Root of Chronic Pain
The first priority after suspected hidden dexamethasone exposure is medical evaluation of steroid withdrawal risk. Ayurveda must not replace emergency care, cortisol replacement when required, or a physician directed withdrawal plan.
Once the steroid issue has been medically stabilised, Ayurveda can become the central long term treatment model for the underlying pain disorder in appropriately selected patients.
At Panaceayur, the objective is not limited to suppressing pain for a few hours. The clinical assessment examines why pain continues and which factors are preventing lasting recovery.
This evaluation may include the location and character of pain, morning stiffness, swelling, range of movement, appetite, digestion, bowel function, sleep, strength, body weight, metabolic health, blood investigations, imaging findings, previous treatments, and current medicines.
In Ayurvedic reasoning, chronic pain may involve aggravated Vata, impaired Agni, accumulation of Ama, obstruction within Srotas, or depletion of the Dhatus that maintain joints, muscles, bones, nerves, and connective tissues.
Charaka Samhita, Chikitsa Sthana, Chapter 28, Vatavyadhi Chikitsa, describes the assessment and treatment of disorders dominated by aggravated Vata. The chapter discusses pain, stiffness, restricted movement, weakness, tissue involvement, and the need to individualise treatment according to the condition of the patient [9].
Madhava Nidana, Chapter 25, Amavata Nidana, describes a pattern in which Ama combines with aggravated Vata and contributes to pain, swelling, stiffness, heaviness, reduced digestive capacity, and systemic discomfort [10].
These classical categories are not automatic replacements for diagnoses such as rheumatoid arthritis or osteoarthritis. They provide an additional framework for identifying the internal factors that may be sustaining the patient’s symptoms.
Depending on the diagnosis and Ayurvedic assessment, treatment may involve measures directed towards Agni correction, Ama reduction, Vata regulation, restoration of Srotas, nourishment of weakened tissues, improved mobility, better sleep, and Rasayana based regeneration.
Deepana and Pachana may be considered when impaired digestion and Ama are prominent. Snehana, Swedana, Basti, local therapies, carefully selected internal medicines, diet correction, and graded movement may be used when clinically appropriate and after steroid safety has been established.
A universal pain formula should not be given to every patient. Someone with active inflammation, poor digestion, diabetes, osteoporosis, nerve compression, or adrenal suppression requires a different plan from someone with age related joint degeneration and no systemic illness.
The intended result is movement away from repeated symptom masking and towards sustained reduction in pain, restoration of mobility, improved strength, normal daily activity, and resolution of the factors maintaining the disorder.
Progress should be followed through pain intensity, swelling, morning stiffness, range of movement, walking capacity, sleep, medicine dependence, blood markers, and imaging where relevant.
What Does Modern Research Suggest About Ayurveda for Joint Pain?
A multicentre randomized controlled trial studied 151 patients with knee osteoarthritis. Participants received either an individualised multimodal Ayurvedic programme or conventional conservative care over 12 weeks [7].
The Ayurvedic group experienced greater improvement in the Western Ontario and McMaster Universities Osteoarthritis Index. The programme included individualised medicines, dietary guidance, lifestyle advice, manual treatments, and movement recommendations.
The results cannot be attributed to one herb or one formulation. They suggest that a comprehensive Ayurvedic treatment model may produce meaningful improvement in appropriately diagnosed knee osteoarthritis, although further research is required to confirm the magnitude of benefit [7].
A separate randomized pilot study compared individualised classical Ayurvedic treatment, methotrexate, and a combination of both in 43 people with rheumatoid arthritis [8].
All three groups showed improvement within the limitations of the small pilot study. The research demonstrated that individualised classical Ayurveda could be evaluated through controlled clinical methods and supported the need for larger trials [8].
These studies do not prove that Ayurveda treats adrenal insufficiency or that every chronic pain disorder can be resolved through the same programme. They support the use of structured and individualised Ayurvedic treatment for selected musculoskeletal conditions.
Can Ayurveda Be Started During Dexamethasone Withdrawal?
Ayurvedic treatment may be planned during the recovery period, but both the medical physician and Ayurvedic physician should know every medicine, supplement, powder, tablet, decoction, oil, and therapy being used.
The Ayurvedic physician should know whether the patient has been prescribed hydrocortisone, prednisone, dexamethasone, diabetes medicines, blood pressure medicines, anticoagulants, or immune suppressing treatment.
Aggressive fasting, vigorous cleansing, strong heat therapy, or unsupervised detoxification should not be started when the patient is weak, dehydrated, vomiting, hypotensive, or at risk of adrenal crisis.
The sequence is important. First establish steroid safety. Then address the original disease through an individualised Ayurvedic treatment model intended to produce deeper and more durable recovery.
How Can Patients Recognise a Potentially Unsafe Pain Product?
A product should be treated cautiously when it claims to be completely natural but produces an unusually dramatic improvement within hours or a few days.
Other warning signs include an incomplete ingredient list, secret formula, no accountable manufacturer, no batch information, no expiry details, no qualified prescriber, and promises that one product can treat every type of pain.
Words such as natural, herbal, traditional, and ancient do not confirm purity. Transparent ingredients, professional accountability, manufacturing quality, independent testing, and appropriate follow up are stronger indicators of safety.
A patient should also seek assessment when missing one or two doses causes severe weakness, body pain, dizziness, nausea, or rapid return of symptoms.
Frequently Asked Questions
Is Qu Feng Huo Lou Dan Under an FDA Recall?
The FDA published a medication health fraud notification advising consumers not to purchase or use Qu Feng Huo Lou Dan. The notice does not identify a lot specific manufacturer recall. It is more accurate to describe it as an FDA public safety warning about a hidden prescription ingredient.
Should I Stop Qu Feng Huo Lou Dan Immediately?
The FDA advises current users to consult a healthcare professional immediately so that withdrawal risk can be assessed and the product can be discontinued safely.
Because the hidden dexamethasone dose is unknown, a patient should not follow a self designed taper.
What Are the Most Common Dexamethasone Withdrawal Symptoms?
Possible symptoms include fatigue, weakness, muscle pain, joint pain, loss of appetite, nausea, vomiting, dizziness, headache, abdominal discomfort, and low blood pressure .
These symptoms can overlap with recurrence of the original pain condition, so medical assessment is important.
Can One or Two Doses Cause Adrenal Suppression?
Significant prolonged adrenal suppression is generally less likely after one or a few doses. Risk becomes more concerning with repeated or prolonged exposure.
However, the dexamethasone quantity in Qu Feng Huo Lou Dan has not been disclosed, and total exposure may be higher when other steroid medicines are also being used.
Can a Morning Cortisol Test Confirm Recovery?
Morning serum cortisol is the recommended first test when confirmation of adrenal recovery is required.
The result should be interpreted by a qualified clinician alongside symptoms, recent steroid exposure, current medicines, and the patient’s medical condition.
How Long Can Adrenal Recovery Take?
Recovery varies considerably. Some people recover relatively quickly, while others may require weeks or months of monitoring.
Official prescribing information warns that relative adrenal insufficiency may persist for months after corticosteroids are discontinued.
Can Ayurveda Replace a Steroid Taper?
Ayurveda should not replace a medically required steroid taper or emergency treatment for adrenal insufficiency.
After immediate steroid safety has been established, an individualised Ayurvedic programme can address the underlying pain disorder and aim for sustained improvement rather than continued temporary suppression.
Why Does Pain Return When the Product Is Stopped?
The pain may return because dexamethasone was suppressing an untreated inflammatory or musculoskeletal disorder.
Pain, weakness, and body aches may also appear as part of corticosteroid withdrawal. Medical evaluation is needed because these possibilities can resemble one another.
Patient Takeaway
The discovery of hidden dexamethasone in pain relief product Qu Feng Huo Lou Dan is not simply a labelling mistake. A person may unknowingly consume a potent prescription steroid without knowing the dose, duration, interaction risk, or danger of withdrawal.
Do not start or repurchase the product. Anyone currently taking it should contact a healthcare professional and provide a complete exposure history.
Severe weakness, persistent vomiting, diarrhoea, fainting, confusion, collapse, or very low blood pressure requires emergency medical care.
Once steroid safety has been addressed, a transparent and individualised Ayurvedic treatment model can focus on the diagnosed source of chronic pain. The objective should be sustained resolution of the factors maintaining pain, restoration of movement and strength, and reduced dependence on repeated symptom suppression.
References
- U.S. Food and Drug Administration. (2026, August 25). Qu Feng Huo Lou Dan may be harmful due to hidden ingredient.
https://www.fda.gov/drugs/medication-health-fraud-notifications/qu-feng-huo-lou-dan-may-be-harmful-due-hidden-ingredient
Used for: Product name, hidden dexamethasone finding, identified sales channels, FDA safety warning, possible adverse effects, safe discontinuation advice, and MedWatch reporting information.
- Beuschlein, F., Else, T., Bancos, I., Hahner, S., Hamidi, O., van Hulsteijn, L., Husebye, E. S., Karavitaki, N., Prete, A., Vaidya, A., Yedinak, C., and Dekkers, O. M. (2024). European Society of Endocrinology and Endocrine Society joint clinical guideline: Diagnosis and therapy of glucocorticoid induced adrenal insufficiency. European Journal of Endocrinology, 190(5), G25 to G51.
https://www.endocrine.org/clinical-practice-guidelines/glucocorticoid-induced-adrenal-insufficiency
Used for: Adrenal suppression thresholds, withdrawal guidance, morning cortisol assessment, recovery monitoring, stress dosing, and recognition of adrenal crisis.
- National Institute of Diabetes and Digestive and Kidney Diseases. (n.d.). Symptoms and causes of adrenal insufficiency and Addison’s disease.
https://www.niddk.nih.gov/health-information/endocrine-diseases/adrenal-insufficiency-addisons-disease/symptoms-causes
Used for: Patient focused symptoms of adrenal insufficiency, causes of tertiary adrenal insufficiency, and the risk associated with suddenly stopping prolonged corticosteroid treatment.
- National Library of Medicine. (2023). Dexamethasone tablets, USP prescribing information. DailyMed.
https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=401ec088-984a-49ab-b317-747c2b9b9e22&type=display
Used for: Dexamethasone adverse effects, infection risk, blood glucose changes, muscle and bone effects, adrenal suppression, and gradual withdrawal warnings.
- Berg, E. A., Dao, L., Yu, R., and Hurtado, C. R. (2024). Artri King induced hypothalamic pituitary adrenal axis disruption: A report of 3 cases. JCEM Case Reports, 2(1), luad154.
https://pubmed.ncbi.nlm.nih.gov/38116163/
Used for: Clinical cases involving an unregulated joint pain supplement associated with undeclared dexamethasone and disruption of adrenal function.
- Dunn, C., Amaya, J., and Green, P. (2023). A case of iatrogenic Cushing’s syndrome following use of an over the counter arthritis supplement. Case Reports in Endocrinology, 2023, 4769258.
https://pubmed.ncbi.nlm.nih.gov/36941974/
Used for: A documented case of Cushing syndrome caused by prolonged ingestion of an arthritis supplement containing hidden dexamethasone.
- Kessler, C. S., Dhiman, K. S., Kumar, A., Ostermann, T., Gupta, S., Morandi, A., Mittwede, M., Stapelfeldt, E., Spoo, M., Icke, K., Michalsen, A., and Witt, C. M. (2018). Effectiveness of an Ayurveda treatment approach in knee osteoarthritis: A randomized controlled trial. Osteoarthritis and Cartilage, 26(5), 620 to 630.
https://pubmed.ncbi.nlm.nih.gov/29426006/
Used for: Modern clinical evidence concerning individualised multimodal Ayurvedic management of knee osteoarthritis, pain, mobility, function, and later follow up.
- Furst, D. E., Venkatraman, M. M., McGann, M., Manohar, P. R., Booth LaForce, C., Sarin, R., Sekar, P. G., Raveendran, K. G., Mahapatra, A., Gopinath, J., and Kumar, P. R. (2011). Double blind, randomized, controlled pilot study comparing classical Ayurvedic medicine, methotrexate, and their combination in rheumatoid arthritis. Journal of Clinical Rheumatology, 17(4), 185 to 192.
https://pubmed.ncbi.nlm.nih.gov/21617554/
Used for: Pilot research evaluating individualised classical Ayurvedic treatment, methotrexate, and their combination in rheumatoid arthritis.
- Charak Samhita Research, Training and Skill Development Centre. (2026). Vatavyadhi Chikitsa. In Charaka Samhita, Chikitsa Sthana, Chapter 28.
https://www.carakasamhitaonline.com/index.php/Vatavyadhi_Chikitsa
Used for: Classical Ayurvedic principles concerning Vata related pain, stiffness, weakness, restricted movement, tissue involvement, and individualised treatment.
- National Institute of Indian Medical Heritage. (n.d.). Amavata Nidana. In Madhava Nidana, Chapter 25.
https://niimh.nic.in/ebooks/madhavanidana/
Used for: Classical description of Amavata involving Ama, aggravated Vata, impaired digestion, pain, swelling, stiffness, heaviness, and systemic discomfort.
